Mechanism of Lassa fever virus Z protein in immune suppression and viral virulence

拉沙热病毒Z蛋白免疫抑制及病毒毒力机制

基本信息

  • 批准号:
    9333725
  • 负责人:
  • 金额:
    $ 78.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-03-08 至 2022-02-28
  • 项目状态:
    已结题

项目摘要

Abstract Title: Mechanism of Lassa fever virus Z protein in immune suppression and viral virulence Lassa fever virus (LASV) is the most significant arenavirus pathogen that causes endemic and lethal hemorrhagic fever (HF) in humans in West Africa with thousand of death annually. Importation of LASV infection to USA and other Western counties has been repeatedly documented due to increased human travel to and from the endemic countries. Currently there is no vaccine and limited treatment options against LASV. Among LASV-infected individuals, there are significant heterogeneity in disease severity, which ranges from asymptomatic infections to multi-organ failure and death, the reason for which is unknown but may partly be due to the different LASV isolates that show sequence variations up to 32%. Molecular determinants for LASV virulence remain unknown. LASV pathogenesis has not been well understood but is associated with a general host immune suppression that is characterized by the lack of early innate immune responses and the absence of effective adaptive immunity. The long-term goal of our work is to understand the mechanisms of LASV virulence and disease pathogenesis in order to develop the much-needed vaccines and antivirals. We have recently discovered a unique ability of the Z protein of several known pathogenic arenaviruses (including LASV) to inhibit the human RIG-i-like receptors (RLRs) RIG-i and MDA5, which are the intracellular sensors of RNA viruses. We have also obtained preliminary evidence to show that the Z proteins from different LASV isolates vary in their ability to inhibit RLRs. In addition, we show that this Z-mediated RLR binding and inhibition is species specific, which may explain the observed differences in disease pathogenesis in different animal species. We hypothesize that the virus- and host-dependent inhibition of RLRs by LASV Z proteins is a novel virulence determinant and propose the following aims to test this hypothesis. Aim 1: Dissect the molecular mechanism of LASV Z-mediated RLR inhibition. Aim 2: Determine the biological role of LASV Z-mediated RLR inhibition in viral virulence. Aim 3: Investigate the species-specific mechanism of LASV Z-mediated of RLR inhibition. These studies focus on a novel immune suppressive and virulent mechanism mediated by LASV Z protein, which will not only make major impacts on both basic and translational research of arenavirus pathogens, but also provide new knowledge in host-pathogen interactions, host antiviral responses, and viral immune evasion mechanisms.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YUYING LIANG其他文献

YUYING LIANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YUYING LIANG', 18)}}的其他基金

Novel multivalent viral vectored tuberculosis vaccines targeting lung immunity
针对肺部免疫的新型多价病毒载体结核疫苗
  • 批准号:
    10738913
  • 财政年份:
    2023
  • 资助金额:
    $ 78.23万
  • 项目类别:
Viral Vectored COVID-19 Vaccines in a Guinea Pig Perinatal Infection Model
豚鼠围产期感染模型中的病毒载体 COVID-19 疫苗
  • 批准号:
    10369372
  • 财政年份:
    2021
  • 资助金额:
    $ 78.23万
  • 项目类别:
Viral Vectored COVID-19 Vaccines in a Guinea Pig Perinatal Infection Model
豚鼠围产期感染模型中的病毒载体 COVID-19 疫苗
  • 批准号:
    10515662
  • 财政年份:
    2021
  • 资助金额:
    $ 78.23万
  • 项目类别:
Receptor tyrosine kinase signaling and influenza viral RNA synthesis
受体酪氨酸激酶信号传导和流感病毒RNA合成
  • 批准号:
    8241210
  • 财政年份:
    2012
  • 资助金额:
    $ 78.23万
  • 项目类别:
Receptor tyrosine kinase signaling and influenza viral RNA synthesis
受体酪氨酸激酶信号传导和流感病毒RNA合成
  • 批准号:
    8426084
  • 财政年份:
    2012
  • 资助金额:
    $ 78.23万
  • 项目类别:
Molecular determinants of virulent arenavirus infection in hosts
宿主强毒沙粒病毒感染的分子决定因素
  • 批准号:
    8060493
  • 财政年份:
    2010
  • 资助金额:
    $ 78.23万
  • 项目类别:
Molecular determinants of virulent arenavirus infection in hosts
宿主强毒沙粒病毒感染的分子决定因素
  • 批准号:
    8259831
  • 财政年份:
    2010
  • 资助金额:
    $ 78.23万
  • 项目类别:
Molecular determinants of virulent arenavirus infection in hosts
宿主强毒沙粒病毒感染的分子决定因素
  • 批准号:
    7889110
  • 财政年份:
    2010
  • 资助金额:
    $ 78.23万
  • 项目类别:
Molecular determinants of virulent arenavirus infection in hosts
宿主强毒沙粒病毒感染的分子决定因素
  • 批准号:
    8460799
  • 财政年份:
    2010
  • 资助金额:
    $ 78.23万
  • 项目类别:
Molecular determinants of virulent arenavirus infection in hosts
宿主强毒沙粒病毒感染的分子决定因素
  • 批准号:
    8651859
  • 财政年份:
    2010
  • 资助金额:
    $ 78.23万
  • 项目类别:

相似海外基金

Multi-component interventions to reducing unhealthy diets and physical inactivity among adolescents and youth in sub-Saharan Africa (Generation H)
采取多方干预措施减少撒哈拉以南非洲青少年的不健康饮食和缺乏身体活动(H 代)
  • 批准号:
    10106976
  • 财政年份:
    2024
  • 资助金额:
    $ 78.23万
  • 项目类别:
    EU-Funded
Exploring the mental health and wellbeing of adolescent parent families affected by HIV in South Africa
探讨南非受艾滋病毒影响的青少年父母家庭的心理健康和福祉
  • 批准号:
    ES/Y00860X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.23万
  • 项目类别:
    Fellowship
Decolonization, Appropriation and the Materials of Literature in Africa and its Diaspora
非洲及其侨民的非殖民化、挪用和文学材料
  • 批准号:
    EP/Y024516/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.23万
  • 项目类别:
    Research Grant
Exploring "Actionable Information" for Learning Improvement in Rural East Africa: A Positive Deviance Approach
探索东非农村地区学习改进的“可行信息”:积极偏差方法
  • 批准号:
    24K00390
  • 财政年份:
    2024
  • 资助金额:
    $ 78.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Water stressed cities: individual choice, access to water and pathways to resilience in sub-Saharan Africa
缺水城市:撒哈拉以南非洲地区的个人选择、水资源获取和恢复力途径
  • 批准号:
    MR/X022943/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.23万
  • 项目类别:
    Fellowship
Protecting Women from Economic shocks to fight HIV in Africa (POWER)
保护非洲妇女免受经济冲击,抗击艾滋病毒 (POWER)
  • 批准号:
    MR/Y003837/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.23万
  • 项目类别:
    Fellowship
Tackling antimicrobial resistance across dentistry in Sub-Saharan Africa.
解决撒哈拉以南非洲牙科领域的抗菌素耐药性问题。
  • 批准号:
    MR/Y019695/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.23万
  • 项目类别:
    Research Grant
ePowerCart - Affordable Mobile Clean Energy for Remote Communities in Rural Sub-Saharan Africa and India
ePowerCart - 为撒哈拉以南非洲和印度农村偏远社区提供经济实惠的移动清洁能源
  • 批准号:
    10076185
  • 财政年份:
    2024
  • 资助金额:
    $ 78.23万
  • 项目类别:
    Collaborative R&D
The Open fracture National Evaluation (ONE) Study - South Africa: Improving outcomes in the care of open fractures in low resource settings
开放性骨折国家评估 (ONE) 研究 - 南非:改善资源匮乏地区开放性骨折的护理效果
  • 批准号:
    MR/Y00955X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.23万
  • 项目类别:
    Fellowship
Recognising & supporting informal mhealth in Africa through grassroots interventions (REIMAGINE)
认识
  • 批准号:
    MR/Y015614/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.23万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了